Ad-hoc | 6 March 2017 12:26
MeVis Medical Solutions AG / Key word(s): Change in Forecast
06-March-2017 / 12:26 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Bremen, March 6, 2017 - MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a
leading provider of medical imaging software, raises its forecast for the
present fiscal year due to the positive business development:
- For fiscal year 2017 (October 1, 2016 to September 30, 2017) a
significant increase in revenues to EUR 17.0 million to EUR 17.5
million is now expected (previous forecast for fiscal year 2017: slight
increase to EUR 16.5 million to EUR 17.0 million).
- For fiscal year 2017 (October 1, 2016 to September 30, 2017) an
increase in the EBIT (earnings before interest and taxes) is expected
to EUR 5.0 million to EUR 5.5 million (previous forecast for fiscal
year 2017: stable EBIT of EUR 4.5 million to EUR 5.0 million).
---------------------------------------------------------------------------
06-March-2017 CET/CEST The DGAP Distribution Services include Regulatory
Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: MeVis Medical Solutions AG
Caroline-Herschel-Str. 1
28359 Bremen
Germany
Phone: +49 421 224 95 0
Fax: +49 421 224 95 999
E-mail: ir@mevis.de
Internet: http://www.mevis.de
ISIN: DE000A0LBFE4
WKN: A0LBFE
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated
Unofficial Market in Berlin, Dusseldorf, Munich,
Stuttgart, Tradegate Exchange
End of Announcement DGAP News Service